Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 6/20 | 0.79 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.79 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.70 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.70 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.68 |
| ▸ | TFEB | P19484 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.60 |
| ▸ | CA1 | P00915 | 1/20 | 0.60 |
| ▸ | CA2 | P00918 | 1/20 | 0.60 |
| ▸ | CA4 | P22748 | 1/20 | 0.60 |
| ▸ | CA7 | P43166 | 1/20 | 0.60 |
| ▸ | CA9 | Q16790 | 1/20 | 0.60 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7915752 | 1.00 | NFE2L2 (0.79) | NFE2L2TRPA1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL1603719 | 1.00 | NFE2L2 (0.79) | NFE2L2TRPA1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL9168164 | 0.91 | NFE2L2 (0.88) | NFE2L2TRPA1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL9168170 | 0.91 | NFE2L2 (0.88) | NFE2L2TRPA1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL713258 | 0.89 | NFE2L2 (1.00) | NFE2L2TRPA1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL713256 | 0.89 | NFE2L2 (1.00) | NFE2L2TRPA1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL4461398 | 0.88 | NFE2L2 (0.64) | NFE2L2TRPA1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL1883472 | 0.88 | NFE2L2 (0.64) | NFE2L2TRPA1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL29580852 | 0.88 | NFE2L2 (0.64) | NFE2L2TRPA1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL16933894 | 0.88 | NFE2L2 (0.64) | NFE2L2TRPA1CYP1A1CYP1A2CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7507851-B2 | Halocombstatins and methods of synthesis thereof | ARIZONA BOARD OF REGENTS, A STATE CORPORATE OF THE STATE OF ARIZONA, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2009-03-24 | — | — | US | disclosed |
| US-20080119649-A1 | HALOCOMBSTATINS AND METHODS OF SYNTHESIS THEREOF | ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY | 2008-05-22 | — | — | US | disclosed |
| EP-1802560-A2 | HALOCOMBSTATINS AND METHODS OF SYNTHESIS THEREOF | Arizona Board Regents, a body corporate of the State of Arizona, acting for and on behalf of Arizona State University (US) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006036743-A2 | HALOCOMBSTATINS AND METHODS OF SYNTHESIS THEREOF | ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2006-04-06 | — | — | WO | disclosed |
| EP-0141271-A3 | TALL OIL FATTY ACIDS - QUALITY IMPROVEMENT | ARIZONA CHEMICAL COMPANY (US) | 1986-02-05 | — | — | EP | disclosed |
| US-4536332-A | ISOMERIZING TRANS-DIMETHOXYSTILBENE TO CIS CONFIGURATION, DISTILLING OUT | ARIZONA CHEMICAL COMPANY (US) | 1985-08-20 | — | — | US | disclosed |
| EP-0141271-A2 | Tall oil fatty acids - quality improvement | ARIZONA CHEMICAL COMPANY (US) | 1985-05-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119649-A1 | HALOCOMBSTATINS AND METHODS OF SYNTHESIS THEREOF | TUBB3, TUBB8B, TUBB8 | NFE2L2 4884/4885TRPA1 4108/4885CYP1A1 4678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.